Discontinued — last reported Q3 '23
Medline, Inc. Convertible Preferred Stock Authorized Shares remained flat by 0.0% to 5B in Q1 2026 compared to the prior quarter.
An increase in authorized shares provides greater capital-raising flexibility but may signal potential future dilution for common shareholders.
This represents the maximum number of convertible preferred shares that the company is legally permitted to issue under...
Standard corporate governance metric; levels are usually set high to provide long-term flexibility.
convertible_preferred_stock_authorized_shares| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | 5B | 5B |
| QoQ Change | — | +0.0% |